[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Clinical Chemistry Analyzer Market: By Product Type (Analyzer, Reagent), By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K, Germany, China, India, Japan, Brazil)

March 2019 | 220 pages | ID: GB791E061D6EN
Azoth Analytics

US$ 2,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
EXECUTIVE SUMMARY

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Clinical Chemistry Analyzer Market. The Global Clinical Chemistry Analyzer Market has been analyzed By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others) and By Product Type (Analyzers and Reagents). The Global Clinical Chemistry Analyzer Market has been analyzed By Region (North America, Europe, Asia-Pacific, Rest of the World) and By Country (U.S, Canada, U.K, Germany, China, India, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Clinical Chemistry Analyzer Market: By Product Type (Analyzer, Reagent), By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K, Germany, China, India, Japan, Brazil)”, Global Clinical Chemistry Analyzer Market is projected to display a positive growth represented by a CAGR of 10.78% during 2018 – 2023.

Over the recent years, global Clinical Chemistry Analyzer market has been witnessing growth, on account of rapid growing diagnostics market, increase in healthcare expenditure, increase in lifestyle diseases like diabetes, cardiovascular diseases, growth in aging population and increasing demand of laboratory automation. Moreover, rapidly increasing number of hospitals and diagnostics laboratories due to surging prevalence of chronic diseases, cancer, vector borne diseases, and blood disorders have been driving the market growth. Clinical chemistry analyzer are the computer-programmed devices utilized for determining and analyzing the levels of sugar and protein present in the blood. These devices within the least possible time come up with an accurate result as they have extremely advanced technologies and are designed for such purpose. Furthermore, presence of favourable government policies and well developed clinical research infrastructure is propelling the growth of market.

In this research report, the market is segmented on the basis of test type and product type, the segment reagents is predicted to hold its dominant position in the market. Amongst the regions, North America accounts for the largest regional share in the global Clinical Chemistry Analyzer market in 2018. Moreover, APAC region is also predicted to maintain its dominant position in the market in forecast period. Presence of large number of people suffering from chronic diseases and growing old age population in emerging nations such as China and Japan is likely to drive the regional market.

The report titled “Global Clinical Chemistry Analyzer Market: By Product Type (Analyzer, Reagent), By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K, Germany, China, India, Japan, Brazil)” has covered and analyzed the potential of global Clinical Chemistry Analyzer market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Clinical Chemistry Analyzer market. Additionally, the report also highlights market entry strategies for various companies across the globe.

SCOPE OF THE REPORT

Global Clinical Chemistry Analyzer Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Clinical Chemistry Analyzer Market – Size, Growth, Forecast
  • By Test Type – Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others
By Product Type – Analyzers & Reagents.

Regional Markets – North America, Europe, Asia-Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Clinical Chemistry Analyzer Market – Size, Growth, Forecast
  • By Test Type – Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others
By Product Type – Analyzers & Reagents.

Country Analysis – U.S, Canada, U.K, Germany, China, India, Japan, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Clinical Chemistry Analyzer Market – Size, Growth, Forecast
  • By Test Type – Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others
Other Report Highlights
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Product Benchmarking
  • Company Analysis –Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens, Danaher Corporation, Thermo Fisher Scientific, Bio Porto, Randox Laboratories, Elitech Group, Horiba
CUSTOMIZATION OF THE REPORT

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY

2. EXECUTIVE SUMMARY

3. STRATEGIC RECOMMENDATIONS

4. CLINICAL CHEMISTRY ANALYZER PRODUCT OUTLOOK

5. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET : GROWTH AND FORECAST

5.1 Global Clinical Chemistry Analyzer Market, By Value (2013-2017) (USD Million)
5.2 Global Clinical Chemistry Analyzer Market, By Value (2018-2023) (USD Million)

6. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET : SEGMENT ANALYSIS (BY TEST TYPE)

6.1 Global Clinical Chemistry Analyzer Market Size, By Test Type,2017 (%)
6.2 Global Clinical Chemistry Analyzer Market Size, By Test Type,2023 (%)

7. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET: SEGMENT ANALYSIS (BY TEST TYPE)

7.1 Global Clinical Chemistry Analyzer Market, By Test Type (Basic Metabolic Profile), By Value (2013-2023) (USD Million)
7.2 Global Clinical Chemistry Analyzer Market, By Test Type (Lipid Profile), By Value (2013-2023) (USD Million)
7.3 Global Clinical Chemistry Analyzer Market, By Test Type (Liver Profile), By Value (2013-2023) (USD Million)
7.4 Global Clinical Chemistry Analyzer Market, By Test Type (Electrolytes), By Value (2013-2023) (USD Million)
7.5 Global Clinical Chemistry Analyzer Market, By Test Type (Renal Profile), By Value (2013-2023) (USD Million)
7.6 Global Clinical Chemistry Analyzer Market, By Test Type (Thyroid Function), By Value (2013-2023) (USD Million)
7.7 Global Clinical Chemistry Analyzer Market, By Test Type (Others), By Value (2013-2023) (USD Million)

8. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET: BY PRODUCT TYPE

8.1 Global Clinical Chemistry Analyzer Market : Analyzers, By Product Type (2013-2023)
8.2 Global Clinical Chemistry Analyzer Market : Reagents, By Product Type (2013-2023)

9. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET: REGIONAL ANALYSIS

9.1 Global Clinical Chemistry Analyzer Market Size, By Region : Breakdown (%)
  9.1.1 Global Clinical Chemistry Analyzer Market Size, By Region,2017 (%)
  9.1.2 Global Clinical Chemistry Analyzer Market Size, By Region,2023 (%)

10. NORTH AMERICA CLINICAL CHEMISTRY ANALYZER MARKET: GROWTH AND FORECAST

10.1 North America Clinical Chemistry Analyzer Market, By Value (2013-2017) (USD Million)
10.2 North America Clinical Chemistry Analyzer Market, By Value (2018-2023) (USD Million)
  10.2.1 North America Clinical Chemistry Analyzer Market, By Test Type, By value (2013-2017) (USD Million)
  10.2.2 North America Clinical Chemistry Analyzer Market, By Test Type, By Value (2018-2023) (USD Million)
  10.2.3 North America Clinical Chemistry Analyzer Market, By Product Type, By Value (2013-2023) (USD Million)
10.3 North America Clinical Chemistry Analyzer Market: Country Analysis (U.S & Canada)
  10.3.1 U.S Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  10.3.2 U.S Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  10.3.3 U.S Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  10.3.4 Canada Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  10.3.5 Canada Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  10.3.6 Canada Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)

11. EUROPE CLINICAL CHEMISTRY ANALYZER MARKET: GROWTH AND FORECAST

11.1 Europe Clinical Chemistry Analyzer Market, By Value (2013-2017) (USD Million)
11.2 Europe Clinical Chemistry Analyzer Market, By Value (2018-2023) (USD Million)
  11.2.1 Europe Clinical Chemistry Analyzer Market, By Test Type, By value (2013-2017) (USD Million)
  11.2.2 Europe Clinical Chemistry Analyzer Market, By Test Type, By Value (2018-2023) (USD Million)
  11.2.3 Europe Clinical Chemistry Analyzer Market, By Product Type, By Value (2013-2023) (USD Million)
11.3 Europe Clinical Chemistry Analyzer Market: Country Analysis (Germany, U.K & Rest of Europe)
  11.3.1 Germany Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  11.3.2 Germany Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  11.3.3 Germany Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  11.3.4 U.K Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  11.3.5 U.K Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  11.3.6 U.K Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  11.3.7 Rest of Europe Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  11.3.8 Rest of Europe Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  11.3.9 Rest of Europe Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)

12. APAC CLINICAL CHEMISTRY ANALYZER MARKET: GROWTH AND FORECAST

12.1 APAC Clinical Chemistry Analyzer Market, By Value (2013-2017) (USD Million)
12.2 APAC Clinical Chemistry Analyzer Market, By Value (2018-2023) (USD Million)
  12.2.1 APAC Clinical Chemistry Analyzer Market, By Test Type, By value (2013-2017) (USD Million)
  12.2.2 APAC Clinical Chemistry Analyzer Market, By Test Type, By Value (2018-2023) (USD Million)
  12.2.3 APAC Clinical Chemistry Analyzer Market, By Product Type, By Value (2013-2023) (USD Million)
12.3 APAC Clinical Chemistry Analyzer Market: Country Analysis (China, Japan, India & Rest of APAC)
  12.3.1 China Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  12.3.2 China Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  12.3.3 China Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  12.3.4 Japan Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  12.3.5 Japan Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  12.3.6 Japan Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  12.3.7 India Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  12.3.8 India Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  12.3.9 India Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)
  12.3.10 Rest of APAC Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
  12.3.11 Rest of APAC Clinical Chemistry Analyzer Market, By Test Type, By Value , (2013-2017) (USD Million)
  12.3.12 Rest of APAC Clinical Chemistry Analyzer Market, By Test Type, By Value, (2018-2023) (USD Million)

13. ROW CLINICAL CHEMISTRY ANALYZER MARKET: GROWTH AND FORECAST

13.1 Rest of ROW Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
13.2 Rest of ROW Clinical Chemistry Analyzer, By Test Type, By Value , (2013-2017) (USD Million)
13.3 Rest of ROW Clinical Chemistry Analyzer,By Test Type, By Value , (2018-2023) (USD Million)
13.2 Brazil Clinical Chemistry Analyzer , By Value , (2013-2023) (USD Million)
13.3 Brazil Clinical Chemistry Analyzer, By Test Type, By Value , (2013-2017) (USD Million)
13.4 Brazil Clinical Chemistry Analyzer,By Test Type, By Value , (2018-2023) (USD Million)

14. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET: MARKET DYNAMICS

14.1 Global Clinical Chemistry Analyzer Market Drivers
14.2 Global Clinical Chemistry Analyzer Market Challenges
14.3 Global Clinical Chemistry Analyzer Market Trends

15. COMPANY PROFILES

15.1 Abbott Laboratories
15.2 Beckman Coulter
15.3 Roche Diagnostics
15.4 Siemens
15.5 Danaher Corporation
15.6 Thermo Fisher Scientific
15.7 Bio Porto
15.8 Randox Laboratories
15.9 Elitech Group
15.10 Horiba

LIST OF FIGURES AND TABLES

Figure 1: Global Clinical Chemistry Analyzer Market Size, By Value, forecast 2013-2017 (USD Million)
Figure 2: Global Population Ages 65 and Above, 2013-2017 (in Billion)
Figure 3: Global Diabetic Population, By Region, 2017 (Million)
Figure 4: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
Figure 5: Number of New Cases of Cancer, In 2018, By Region, (% of Total)
Figure 6: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 7: Global Clinical Chemistry Analyzer Market Size, By Value, Forecast, 2018-2023 (USD Million)
Figure 8: Distributions of persons aged 60 years or above by region in millions, 2030
Figure 9: Projected global population aged 60 years & above (In Billions)
Figure 10: Projected global population (In Billions)
Figure 11: Obese Population, By Country, 2017 (In Millions)
Figure 12: Global Clinical Chemistry Analyzer Market Size, By Test Type, 2017 (%)
Figure 13: Global Clinical Chemistry Analyzer Market Size, By Test Type, 2023 (%)
Figure 14: Global Clinical Chemistry Analyzer Market, By Test Type (Basic Metabolic Panel) 2013-2017 (USD Million)
Figure 15: Global Clinical Chemistry Analyzer Market, By Test Type (Basic Metabolic Panel) 2018-2023 (USD Million)
Figure 16: Global Clinical Chemistry Analyzer Market, By Test Type (Lipid Profile) 2013-2017 (USD Million)
Figure 17: Global Clinical Chemistry Analyzer Market, By Test Type (Lipid Profile) 2018-2023 (USD Million)
Figure 18: Global Clinical Chemistry Analyzer Market, By Test Type (Liver Profile) 2013-2017 (USD Million)
Figure 19: Global Clinical Chemistry Analyzer Market, By Test Type (Liver Profile) 2018-2023 (USD Million)
Figure 20: Global Clinical Chemistry Analyzer Market, By Test Type (Electrolytes) 2013-2017 (USD Million)
Figure 21: Global Clinical Chemistry Analyzer Market, By Test Type (Electrolytes) 2018-2023 (USD Million)
Figure 22: Global Clinical Chemistry Analyzer Market, By Test Type (Renal Profile) 2013-2017 (USD Million)
Figure 23: Global Clinical Chemistry Analyzer Market, By Test Type (Renal Profile) 2018-2023 (USD Million)
Figure 24: Global Clinical Chemistry Analyzer Market, By Test Type (Thyroid Function) 2013-2017 (USD Million)
Figure 25: Global Clinical Chemistry Analyzer Market, By Test Type (Thyroid Function) 2018-2023 (USD Million)
Figure 26: Global Clinical Chemistry Analyzer Market, By Test Type (Others) 2013-2017 (USD Million)
Figure 27: Global Clinical Chemistry Analyzer Market, By Test Type (Others) 2018-2023 (USD Million)
Figure 28: Global Clinical Chemistry Analyzer Market, By Type (Analyzers) 2013-2017 (USD Million)
Figure 29: Global Clinical Chemistry Analyzer Market, By Type (Analyzers) 2018-2023 (USD Million)
Figure 30: Global Clinical Chemistry Analyzer Market, By Product Type (Reagents) 2013-2017 (USD Million)
Figure 31: Global Clinical Chemistry Analyzer Market, By Product Type (Reagents) 2018-2023 (USD Million)
Figure 32: Reagents offered by Randox
Figure 33: Global Clinical Chemistry Analyzer Market Size, By Region, 2017 (%)
Figure 34: Global Clinical Chemistry Analyzer Market Size, By Region, 2023F (%)
Figure 35: North America Clinical Chemistry Analyzer Market Size, By Value, 2013-2017 (USD Million)
Figure 36: North America Clinical Chemistry Analyzer Market Size, By Value, Forecast, 2018-2023 (USD Million)
Figure 37: North America Population, 2013-2017 (in Billions)
Figure 38: North America Population 65 & above, 2013-2017 (in Millions)
Figure 39: Number of People Living With Blood Cancer in Canada, 2016
Figure 40: Number of Blood Cancer Cases in United States, 2018
Figure 41: North America Diseases Outlook
Figure 42: United States health care expenditure per capita,2013-2016(USD)
Figure 43: Canada health care expenditure per capita,2013-2016(USD)
Figure 44: North America population aged 65 and above, 2013-2017 (% of total)
Figure 45: North America Healthcare Cost Per Capita, 2017 (USD)
Figure 46: North America GDP per Capita, 2013-2017 (USD)
Figure 47: North America Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 48: North America Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2018-2023 (USD Million)
Figure 49: North America Clinical Chemistry Analyzer Market, By Product Type, By Value, 2013-2017 (USD Million)
Figure 50: North America Clinical Chemistry Analyzer Market Size, By Countries, 2017 (%)
Figure 51: North America Clinical Chemistry Analyzer Market Size, By Countries, 2023F (%)
Figure 52: U.S Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 53: U.S., Population ages 65 and above, 2013-2017 (% of total)
Figure 54: U.S., Population ages 65 and above, Forecast (In Millions)
Figure 55: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 56: U.S., GDP (Current USD), 2013-2017 (In USD Trillion)
Figure 57: Diabetes Estimates in 2017
Figure 58: Number of Different Types of Laboratories in Unites States, 2018
Figure 59: Number of People Living With Different Type of Blood Cancers in US
Figure 60: Medical Infrastructure Outlook in USA
Figure 61: U.S Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 62: U.S Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 63: Canada Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 64: Canada Population Ages 65 and above, (% of Total, (2013-2017)
Figure 65: Number Hospitals Establishments in Canada, By Province, 2015
Figure 66: Estimated prevalence and cost of diabetes in Canada
Figure 67: New Blood Cancer Cases in Canada, 2018, (% of Total)
Figure 68: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 69: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 70: Overweight and Obese Population in Canada, 2015-2017 (% of total)
Figure 71: Canada, Population ages 65 and above, 2012-2017 (% of total)
Figure 72: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 73: Canada diabetic population, 2017
Figure 74: Canada Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 75: Canada Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2018-2023 (USD Million)
Figure 76: Europe Clinical Chemistry Analyzer Market Size, By Value, 2013-2017 (USD Million)
Figure 77: Europe Clinical Chemistry Analyzer Market Size, By Value, Forecast, 2018-2023 (USD Million)
Figure 78: Top 5 countries for number of people with diabetes (18-99 years), 2017
Figure 79: Prevalence (%) estimates of diabetes (18-99 years) in Europe, 2017 & 2045
Figure 80: EU-5 Socio-Economical Statistics, 2017
Figure 81: Europe Health Expenditure, By Select Country, 2016 (% of GDP)
Figure 82: Europe Population ages 65 years and above (% of total population), 2013-17
Figure 83: Prevalence of Diabetes (Age 18+), 2017 & 2045E(In Million)
Figure 84: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Figure 85: Cause of Death, EU-28, 2015, Per 1000000 inhabitants, Both Sex
Figure 86: Europe Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 87: Europe Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 88: Europe Clinical Chemistry Analyzer Market, By Product Type, By Value, 2013-2017 (USD Million)
Figure 89: Europe Clinical Chemistry Analyzer Market Size, By Countries, 2017 (%)
Figure 90: Europe Clinical Chemistry Analyzer Market Size, By Countries, 2023F (%)
Figure 91: Germany Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 92: Germany, Leukemia Incidences, 2014 & 2018E
Figure 93: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 94: Germany, Cause of Deaths, Percentage Change ,2007-2017
Figure 95: Germany, Cause of Deaths, Percentage Change ,2007-2017
Figure 96: Germany Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 97: Germany Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 98: U.K Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 99: U.K Population, 2013-2017 (in Millions)
Figure 100: U.K Population 65 & Above, 2013-2017 (in Millions)
Figure 101: Primary diagnosis of obesity in England, by age group
Figure 102: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD)
Figure 103: U.K, Population Ages 65 and Above (% of total), 2012-2017
Figure 104: UK, Prevalence of Cancer, 2018, (% of Total)
Figure 105: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 106: U.K, Cause of Death, Percentage Change Between 2007-2017
Figure 107: U.K Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 108: U.K Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 109: Rest of Europe Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 110: France, Prevalence of Cancer, 2018, (% of Total)
Figure 111: France, Population Ages 65 and Above (% of total), 2012-2017
Figure 112: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
Figure 113: Italy, Population Ages 65 and Above (% of total), 2012-2017
Figure 114: Italy, Healthcare Infrastructure Related Statistics
Figure 115: Italy, Prevalence of Cancer, 2018, (% of Total)
Figure 116: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 117: Italy, Cause of Death, Percentage Change Between 2007-2017
Figure 118: Rest of Europe Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 119: Rest of Europe Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 120: APAC Clinical Market Size, By Value, 2013-2017 (USD Million)
Figure 121: APAC Clinical Chemistry Analyzer Market Size, By Value, Forecast, 2018-2023 (USD Million)
Figure 122: East Asia & Pacific Total Population, 2013-2017 (Billions)
Figure 123: East Asia & Pacific 65 & above Population, 2013-2017 (Millions)
Figure 124: Key Healthcare industry issues to be addressed
Figure 125: Prevalence of diabetes in the WHO Western Pacific Region, 2030
Figure 126: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Figure 127: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 128: Diabetes Prevalence (% of population ages 20 to 79), By Selected Country, 2017
Figure 129: Obesity Rate, By Selected Country, 2017 (In Percentage)
Figure 130: Cancer Incidences in Asia, (% of Total), 2018
Figure 131: Share of Malaria Cases in South East Asia, 2016, (% 0f total)
Figure 132: APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 133: APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 134: APAC Clinical Chemistry Analyzer Market, By Product Type, By Value, 2013-2023 (USD Million)
Figure 135: APAC Clinical Chemistry Analyzer Market Size, By Countries, 2017 (%)
Figure 136: APAC Clinical Chemistry Analyzer Market Size, By Countries, 2023F (%)
Figure 137: China Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 138: China Oil Production (Million tonnes)
Figure 139: Life expectancy in China 1990-2017
Figure 140: Diabetes in adults (20-79 years)in China, 2017 and 2045 (in 1000’s)
Figure 141: China, Cancer Incidences (in Million)
Figure 142: China, Cause of Death, Percentage Change Between 2007-2017
Figure 143: China, Healthcare Outlook
Figure 144: China, Cancer Prevalence, By Type, (2018)
Figure 145: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 146: China, Share of Urban Population, 2012-2017 (In %)
Figure 147: China, Total Population, 2013-2021F (In Billion)
Figure 148: China Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 149: China Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 150: Japan Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 151: Diabetes Scenario in Japan , 2017 & 2045
Figure 152: Japan, Cause of Death, Percentage Change Between 2007-2017
Figure 153: Japan, Healthcare Outlook
Figure 154: Japan, Cancer Prevalence, By Type, (2018)
Figure 155: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 156: Japan Healthcare Expenditure Outlook (%)
Figure 157: Japan, Population ages 65 and above, 2012-2016 (% of total)
Figure 158: Japan Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 159: Japan Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 160: India Clinical Chemistry Market Size, By Value, 2013-2023 (USD Million)
Figure 161: Diabetes Scenario in India , 2017 & 2045
Figure 162: India, Blood Disorders Incidences in Children, By Type
Figure 163: India, Diseases Outlook
Figure 164: India, Population ages 65 and above, 2013-2017
Figure 165: India, Total Population, 2013-2023F (In Billion)
Figure 166: India, Medical Industry Outlook
Figure 167: India Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 168: India Clinical Chemistry Analyzer Market Size, By Test Type, By value , 2018-2023 (USD Million)
Figure 169: Rest of APAC Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 170: Proportion of total Population Aged 60 or Above in 2050 (in percent)
Figure 171: Rest of APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 172: Rest of APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 173: ROW Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 174: ROW Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 175: ROW Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 176: Brazil Clinical Chemistry Market Size, By Value, 2013-2023 (USD Million)
Figure 177: Brazil, Population ages 65 and above, 2012-17 (% of total)
Figure 178: Brazil, GDP, 2012-2017 (In USD Trillion)
Figure 179: Brazil health expenditure as a share of GDP, 2016
Figure 180: Brazil Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 161: Diabetes Scenario in India , 2017 & 2045
Figure 162: India, Blood Disorders Incidences in Children, By Type
Figure 163: India, Diseases Outlook
Figure 164: India, Population ages 65 and above, 2013-2017
Figure 165: India, Total Population, 2013-2023F (In Billion)
Figure 166: India, Medical Industry Outlook
Figure 167: India Clinical Chemistry Analyzer Market Size, By Test Type, By value, 2013-2017 (USD Million)
Figure 168: India Clinical Chemistry Analyzer Market Size, By Test Type, By value , 2018-2023 (USD Million)
Figure 169: Rest of APAC Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 170: Proportion of total Population Aged 60 or Above in 2050 (in percent)
Figure 171: Rest of APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 172: Rest of APAC Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 173: ROW Clinical Chemistry Analyzer Market Size, By Value, 2013-2023 (USD Million)
Figure 174: ROW Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Figure 175: ROW Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2018-2023 (USD Million)
Figure 176: Brazil Clinical Chemistry Market Size, By Value, 2013-2023 (USD Million)
Figure 177: Brazil, Population ages 65 and above, 2012-17 (% of total)
Figure 178: Brazil, GDP, 2012-2017 (In USD Trillion)
Figure 179: Brazil health expenditure as a share of GDP, 2016
Figure 180: Brazil Clinical Chemistry Analyzer Market Size, By Test Type, By value ,2013-2017 (USD Million)
Table A: Medical Tourism Index, By Region and Top Destinations
Table B: Medical Tourism Market Drivers
Table C: Germany, Healthcare Related Statistics, 2017
Table D: Germany, Prevalence of Cancer, 2018 (% of total)
Table E: South-East Asia regional markers: Historic and Forecast
Table F: Western-Pacific regional markers: Historic and Forecast
Table G: Lung Cancer in Brazil , 2017
Table H: Healthcare spending pattern in Brazil (In USD)


More Publications